Cargando…
Imaging features of fumarate hydratase-deficient renal cell carcinomas: a retrospective study
BACKGOUND: Fumarate hydratase-deficient renal cell carcinoma (FH-RCC) is a subtype of RCC that is increasingly recognized pathologically. The aim of this study was to evaluate the imaging features of FH-RCC on computed tomography (CT), magnetic resonance imaging (MRI), and fluorodeoxyglucose positro...
Autores principales: | Nikolovski, Ines, Carlo, Maria I., Chen, Ying-Bei, Vargas, Hebert Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893914/ https://www.ncbi.nlm.nih.gov/pubmed/33608050 http://dx.doi.org/10.1186/s40644-021-00392-9 |
Ejemplares similares
-
Targeting strategies in the treatment of fumarate hydratase deficient renal cell carcinoma
por: Lindner, Andrea Katharina, et al.
Publicado: (2022) -
Structural basis of fumarate hydratase deficiency
por: Picaud, Sarah, et al.
Publicado: (2011) -
Fumarate hydratase-deficient renal cell carcinoma in extended remission with bevacizumab and erlotinib
por: Tomar, Shubham, et al.
Publicado: (2022) -
Genomic and transcriptomic features between primary and paired metastatic fumarate hydratase–deficient renal cell carcinoma
por: Liang, Jiayu, et al.
Publicado: (2023) -
HIF and fumarate hydratase in renal cancer
por: Sudarshan, S, et al.
Publicado: (2007)